<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<STUDY_SET>
    <STUDY alias="DRP007656" center_name="KEIO-SM" accession="DRP007656">
        <IDENTIFIERS>
            <PRIMARY_ID label="BioProject ID">PRJDB12237</PRIMARY_ID>
        </IDENTIFIERS>
        <DESCRIPTOR>
            <STUDY_TITLE>Feeder cell-induced stem cell memory-like CAR-T cells</STUDY_TITLE>
            <STUDY_TYPE existing_study_type="Other"/>
            <STUDY_ABSTRACT>Stem cell memory-like CD8+ CAR-T cells can be induced by co-culturing activated CD8+ CAR-T cells with OP9 feeder cells that express the Notch ligand, human Delta-like 1 (OP9-hDLL1), which we named CAR-iTSCM. CAR-iTSCM cells showed superior proliferative capacity, better resistance to cell death, in vivo persistence, and more potent antitumor effects compared with conventional CAR-T cells</STUDY_ABSTRACT>
            <CENTER_PROJECT_NAME>Feeder cell-induced stem cell memory-like CAR-T cells</CENTER_PROJECT_NAME>
            <RELATED_STUDIES>
                <RELATED_STUDY>
                    <RELATED_LINK>
                        <DB>bioproject</DB>
                        <ID>PRJDB12237</ID>
                        <LABEL>PRJDB12237</LABEL>
                    </RELATED_LINK>
                    <IS_PRIMARY>true</IS_PRIMARY>
                </RELATED_STUDY>
            </RELATED_STUDIES>
            <STUDY_DESCRIPTION>Stem cell memory-like CD8+ CAR-T cells can be induced by co-culturing activated CD8+ CAR-T cells with OP9 feeder cells that express the Notch ligand, human Delta-like 1 (OP9-hDLL1), which we named CAR-iTSCM. CAR-iTSCM cells showed superior proliferative capacity, better resistance to cell death, in vivo persistence, and more potent antitumor effects compared with conventional CAR-T cells</STUDY_DESCRIPTION>
        </DESCRIPTOR>
    </STUDY>
</STUDY_SET>
